Blue Shield of California is trying to encourage its members to live like those in “blue zones” by offering access to the Blue Zones Challenge App, the insurer announced last week. Blue zones are…
Continue Reading
Global healthcare AI platform Ubie and the American Kidney Fund (AKF) will collaborate to fine-tune Ubie’s AI-enabled symptom checker for kidney disease detection with the aim of accelerating a patient’s time to treatment. Ubie’s AI…
Continue Reading
Fujifilm and Juntendo Hospital in Japan have developed an AI that can accurately predict the risk of falls among outpatients using hospital data. Their research team collated over 500 features associated with falls, including age…
Continue Reading
News
The Coalition for Health AI publishes a draft framework for the responsible use of AI in healthcare and solicits public comment. CHAI also posted a draft document of Assurance Reporting Checklists for self-reporting and…
Continue Reading
Canary Speech, maker of AI-enabled speech analysis software, announced it scored $13 million in Series A funding. Cortes Capital (Love’s Private Equity) led the round, with participation from SMK (Japan), Hackensack Meridian Health and Sorenson…
Continue Reading
When designed for humans, AI and technology have the power to change lives. Digireha Inc., a digital health company headquartered in Tokyo, Japan, is proving this by challenging innovation in rehabilitation through the use…
Continue Reading
What You Should Know:
– Canary Speech, Inc. (Canary), a pioneer in AI-powered voice biomarker technology, announced today it has closed a $13M Series A funding round.
– The round was led by Cortes Capital, LLC…
Continue Reading
Aevice Health obtains $1M investment for Japan, US expansionSingapore-based respiratory health IT maker Aevice Health has received a $1 million investment from A&D Company for its expansion in the United States and Japan.
Based on…
We evaluated the effectiveness of a mobile health (mHealth) intervention for diabetic kidney disease patients by conducting a 12-month randomized controlled trial among 126 type 2 diabetes mellitus patients with moderately increased albuminuria (urinary…
Continue Reading
Dr. Jayawant Fuke, Senior Director of Lifecycle Safety, IQVI Hye Jin Choi, R. Ph., Sr. Director of Regulatory Affairs and Drug Development Solutions, IQVIA Asia Pacific The biopharmaceutical market within the Japan and Asia-Pacific…
Continue Reading
